Skip to main content

Table 1 Distribution of stroke cases and controls by type and CT/OS component

From: Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

  E-alone E+P CaD DM CT OS
Overall cases 351 438 838 1,110 1,672 373
Ischemic 263 319 575 695 1,110 226
Hemorrhagic 48 76 132 190 280 61
Other cases 40 43 131 225 282 86
Controls 351 438 838 1,110 1,672 373
  1. CaD, calcium and vitamin D versus placebo supplementation; CT, randomized controlled trial; DM, low-fat dietary modification versus usual diet; E-alone, estrogen versus placebo; E+P, estrogen plus progestin versus placebo; OS, observational study.